Revolutionizing Pain Management through Virtual Reality
At QTC, we are at the forefront of transforming pain management through the power of virtual reality. Our mission is to pioneer the development and application of VR technology as a Type III medical device, offering a groundbreaking alternative for treating acute pain. We are committed to advancing medical science through rigorous clinical trials in prestigious hospitals across China, demonstrating the efficacy and potential of VR therapy.
Backed by leading investors like Tencent, our goal is to improve the quality of life for patients worldwide by harnessing the intersection of technology and healthcare, making effective pain management accessible and non-invasive. QTC is not just about innovation; it's about a future where pain relief is immediate, comprehensive, and devoid of side effects, marking a new era in therapeutic care
Science
The science of using Virtual Reality (VR) to treat pain is rooted in the concept of immersive distraction and the modulation of pain pathways in the brain. VR technology engages patients in a fully immersive, multi-sensory environment that diverts their attention away from the pain, effectively reducing pain perception. This method leverages the brain's ability to influence pain signals through cognitive processes. By engaging the patient's visual, auditory, and sometimes even tactile senses in a controlled, virtual world, VR therapy can alter the way the brain processes pain signals, leading to significant pain relief.
Research and clinical trials have demonstrated that VR can effectively decrease acute pain, anxiety, and the need for pain medication, by offering a novel, interactive way to manage and control pain experiences. This innovative approach not only addresses physical symptoms but also contributes to the emotional and psychological well-being of patients, showcasing VR's potential as a holistic pain management solution.
News
We are honored to announce that our pioneering research on the use of Virtual Reality for pain management post-thoracoscopic surgery has been accepted for presentation at the 32nd European Conference on General Thoracic Surgery, the most prestigious gathering in the field. This recognition at the conference, to be held in Barcelona, Spain, showcases the groundbreaking impact of our work at QTC and the potential of VR technology to revolutionize post-operative care. We eagerly anticipate the opportunity to share our insights and contribute to the advancement of thoracic surgery and pain management
